Innovative Model Offerings MIMETAS specializes in advanced 3D human disease models and organ-on-a-chip technology, providing a unique platform that appeals to pharmaceutical companies seeking cutting-edge solutions for drug development and precision medicine.
Strategic Partnerships Recent collaborations with Roche and Astellas Pharma demonstrate MIMETAS's ability to build partnerships targeting complex disease areas like inflammatory bowel disease and cancer, opening opportunities for joint research and licensing of their organ models.
Product Expansion The launch of organoid tubules such as Colon1 and Kidney2 and ASC-derived tubular organoids presents new product lines for biotech and pharma clients focusing on organ-specific disease modeling and high-throughput testing.
Award and Recognition Receiving the Dutch Innovation Award in 2022 positions MIMETAS as a credible innovator, which can be leveraged to attract investment and new customer partnerships looking for validated, award-winning technologies.
Emerging Market Potential With a revenue range of $1M to $10M and ongoing funding, MIMETAS operates in a niche but growing biotech segment that offers substantial sales opportunities for providers of related research tools, materials, and customized disease modeling services.
$250M$500M
$10M$25M
$1M$10M
$25M$50M
$1M$10M
$1M$10MMIMETAS uses 8 technology products and services including Facebook Pixel, Microsoft Excel, Microsoft 365, and more. Explore MIMETAS's tech stack below.
| MIMETAS Email Formats | Percentage |
| F.Last@mimetas.com | 31% |
| First.Last@mimetas.com | 20% |
| First@mimetas.com | 18% |
| F.Last@mimetas.com | 31% |
Biotechnology ResearchNetherlands51-200 Employees
We strive to contribute to groundbreaking therapies with our screenable, physiologically relevant 3D human disease models. By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. For more information, visit: www.mimetas.com.
Company Overview
Media & News
Funding & FinancialsMIMETAS has raised a total of $2.3M of funding over 1 rounds. .
MIMETAS's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsMIMETAS has raised a total of $2.3M of funding over 1 rounds. .
MIMETAS's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com